Foundations of gastrointestinal-based drug delivery and future developments

JN Chu, G Traverso - Nature Reviews Gastroenterology & Hepatology, 2022 - nature.com
Gastrointestinal-based drug delivery is considered the preferred mode of drug
administration owing to its convenience for patients, which improves adherence. However …

Oral delivery of micro/nanoparticulate systems based on natural polysaccharides for intestinal diseases therapy: Challenges, advances and future perspectives

AM Dos Santos, SG Carvalho, AB Meneguin… - Journal of Controlled …, 2021 - Elsevier
Colon-targeted oral delivery of drugs remains as an appealing and promising approach for
the treatment of prevalent intestinal diseases (ID), such as inflammatory bowel disease (IBD) …

A review on 5-aminosalicylic acid colon-targeted oral drug delivery systems

HS Sardo, F Saremnejad, S Bagheri, A Akhgari… - International Journal of …, 2019 - Elsevier
Site-specific colon drug delivery is a practical approach for the treatment of local diseases of
the colon with several advantages such as rapid onset of action and reduction of the dosage …

AGA technical review on the management of mild-to-moderate ulcerative colitis

S Singh, JD Feuerstein, DG Binion, WJ Tremaine - Gastroenterology, 2019 - Elsevier
Most patients with ulcerative colitis (UC) have mild-to-moderate disease activity, with low risk
of colectomy, and are managed by primary care physicians or gastroenterologists. Optimal …

Defects in microvillus crosslinking sensitize to colitis and inflammatory bowel disease

B Mödl, M Awad, D Zwolanek, I Scharf… - EMBO …, 2023 - embopress.org
Intestinal epithelial cells are covered by the brush border, which consists of densely packed
microvilli. The Intermicrovillar Adhesion Complex (IMAC) links the microvilli and is required …

Curcumin-qingdai combination for patients with active ulcerative colitis: a randomized, double-blinded, placebo-controlled trial

S Ben-Horin, N Salomon, G Karampekos… - Clinical …, 2024 - Elsevier
Background & Aims We evaluated the efficacy of herbal combination of curcumin-QingDai
(CurQD) in active ulcerative colitis (UC). Methods Part I was an open-label trial of CurQD in …

Gut microbiota-driven drug metabolism in inflammatory bowel disease

F Crouwel, HJC Buiter… - Journal of Crohn's and …, 2021 - academic.oup.com
Abstract Background and Aims The gut microbiota plays an important role in the
metabolization and modulation of several types of drugs. With this study we aimed to review …

Selenium-enriched Bifidobacterium longum DD98 effectively ameliorates dextran sulfate sodium-induced ulcerative colitis in mice

Y Hu, X Jin, F Gao, T Lin, H Zhu, X Hou, Y Yin… - Frontiers in …, 2022 - frontiersin.org
The pathogenesis of ulcerative colitis (UC) is complicated with impaired intestinal epithelial
barrier and imbalanced gut microbiota. Both selenium and probiotics have shown effects in …

Impact of gastrointestinal disease states on oral drug absorption–implications for formulation design–a PEARRL review

A Effinger, CM O'Driscoll, M McAllister… - Journal of Pharmacy …, 2019 - academic.oup.com
Objectives Drug product performance in patients with gastrointestinal (GI) diseases can be
altered compared to healthy subjects due to pathophysiological changes. In this review …

Development and optimization of RP-UHPLC method for mesalamine through QbD approach

DK Shill, U Kumar, ASMM Al Hossain… - … University Journal of …, 2022 - banglajol.info
The current study aimed at developing and optimizing a prompt, simple and efficient RP-
UHPLC method based on Quality by Design (QbD) for analyzing mesalamine. Experimental …